Executive Function Assessment in Cognitive Disorders

Executive functions encompass a suite of higher-order cognitive processes—including planning, working memory, mental flexibility and inhibitory control—that enable goal-directed behaviour. Impairments in these functions are hallmark features of many neurological and psychiatric conditions, ranging from mild cognitive impairment and Alzheimer’s disease to stroke and frontotemporal dementia. Effective assessment of executive function is essential not only for accurate clinical diagnosis but also for monitoring disease progression and guiding rehabilitation strategies.

A diverse array of assessment approaches has been developed, from brief bedside screening batteries to comprehensive neuropsychological test batteries and digital platforms. Common tools include the Frontal Assessment Battery (FAB) and the INECO Frontal Screening (IFS), which provide rapid indices of overall executive capacity. More elaborate protocols may combine verbal fluency tasks, set-shifting paradigms and dual-task challenges. Neuroimaging measures, such as cortical thickness mapping, increasingly augment behavioural assessment by revealing structural correlates of executive dysfunction.

At a global level, standardising executive function assessment supports early detection of cognitive decline, facilitates cross-cultural comparisons and informs public health initiatives aimed at dementia prevention. In clinical practice, reliable measurement of executive impairment aids prognostic stratification and the evaluation of interventions ranging from cognitive training to pharmacotherapy.

Research from Nature Portfolio

Longitudinal analysis of patients with amnestic mild cognitive impairment has shown that those exhibiting frontal-executive deficits at baseline face a substantially elevated risk of conversion to dementia. Neuroimaging in this cohort revealed widespread cortical thinning, notably within frontal regions, underscoring the link between executive dysfunction and neurodegenerative progression. These findings highlight the prognostic value of targeted executive tests and support prioritising early intervention for individuals with combined memory and frontal-executive impairment.

Executive Function Assessment in Cognitive Disorders publication trend

The graph below shows the total number of articles in executive function assessment in cognitive disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Executive function: A set of cognitive processes responsible for planning, decision-making, problem solving and self-control.

Mild cognitive impairment (MCI): A clinical condition characterised by cognitive decline greater than expected for age and education, not interfering markedly with daily activities.

Frontal Assessment Battery (FAB): A brief bedside tool comprising six tasks that sample key components of frontal lobe function.

INECO Frontal Screening (IFS): A concise neuropsychological instrument designed to assess multiple executive domains, including working memory and inhibitory control.

Cortical thinning: Reduction in the thickness of the cerebral cortex, often measured by magnetic resonance imaging as a marker of neurodegeneration.

Dementia conversion: The progression from a prodromal cognitive state, such as mild cognitive impairment, to a diagnosable dementia syndrome.

References

1. Frontal-executive dysfunction affects dementia conversion in patients with amnestic mild cognitive impairment. Scientific Reports (2020).
2. “Try to Build This Bunny as Fast as Possible without Using Red or Pink Bricks”: How Simple Assembly Tasks Might Aid in Detecting People with Mild Cognitive Impairment and Dementia. Brain Sciences (2023).
3. Utility of the INECO Frontal Screening and the Frontal Assessment Battery in detecting executive dysfunction in early-onset cognitive impairment and dementia. Journal of the International Neuropsychological Society (2023).
4. Evaluation of sensitivity and specificity of the INECO Frontal Screening and the Frontal Assessment Battery in mild cognitive impairment. Dementia & Neuropsychologia (2021).